Stay updated on Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page
- Check7 days agoChange DetectedThe record now shows that recruitment has ended with a 'No longer looking for participants' note. The revision history has a new version tag 'v3.6.0' and the older 'v3.5.5' entry was removed.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This reflects a frontend template update rather than changes to the study data.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a backend software update and does not alter study records or user-visible content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe study record was updated to reflect that results have been posted, adding result content for outcome measures and adverse events alongside the current study status. A prior results submission/revision entry was removed, aligning the history with the newer posted-results version.SummaryDifference0.7%

- Check64 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.1%

- Check86 days agoChange DetectedCore study content sections were added to the record, including Study Description, Study Status, Arms and Interventions, Outcome Measures, Baseline Characteristics, Participant Flow, Adverse Events, References, and Document Section. The update also notes a Returned date (2026-03-19) and that Quality Control Review Has Not Concluded.SummaryDifference1%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.